S. Lale Tokgözoğlu graduated from the Hacettepe University Faculty of Medicine in 1982.
Active in EAS in various roles over many years, she is the current past-President of EAS, and was the President of the 77th EAS Congress in İstanbul. She also served as the president of the ‘Atherosclerosis and Vascular Biology Working Group of the ESC’ between 2008 and 2010. She has served on the boards of the ESC and IAS Committees, and the Prevention Association of ESC. as Member-at-Large. She has been serving on the Scientific Program Committee of ESC since 1995. She has been a member of the young investigator award committees of the IAS.
Prof. Tokgözoğlu has been elected to the ‘Science Academy in Turkey’ in 2014.

Prof. Tokgözoğlu has served as the Secretary of the Lipid Working Group of the Turkish Society of Cardiology between 1994 and 1996, as President of the Lipid Working Group of the Turkish Society of Cardiology between 1998 and 2000. She has been on the Executive Committee of the Turkish Society of Cardiology for 6 years between 2000 and 2006 and as Vice President between 2008 and 2010 and the President of the Turkish Society of Cardiology between 2014-2016. She was the first female President of this society in its history of 52 years. She has chaired the ‘Research Committee of the Turkish Society of Cardiology’ for 4 years. She is the founding member of the Atherosclerosis Research and Education Society in Turkey. Prof Tokgözoğlu is one of the authors of the ‘National Heart Health Policy’ for Turkey. She has been on the Guideline Committee for the Prevention of Coronary Heart Disease in Turkey in 1995 and in 2002 when the Guidelines were revised.

Prof Tokgözoğlu has more than 400 publications, has authored 3 books and several book chapters. Prof. Tokgözoğlu is on the Editorial Board for European Heart Journal, Atherosclerosis, Anatolian Journal of Cardiology and Archives of the Turkish Society of Cardiology. Prof. Tokgözoğlu is the Fellow of the American College of Cardiology (FACC) and the European Society of Cardiology (FESC). Prof. Tokgözoğlu has been an author on the EAS/ESC dyslipidemia guidelines in 2011, 2016 & 2019.

BSc(hons), MBChB, MD, MPhil (Cantab), FRCP (Lon), FRCP (Ed), FACC, FESC, FAHA

Kausik Ray is Professor of Public Health at the School of Public Health, the Director of the Imperial Centre for Cardiovascular Diseas Prevention and the Deputy Director of the Imperial Clinical Trial Unit, Imperial College London and a Consultant Cardiologist.

Professor Ray received his medical education (MBChB) at the University of Birmingham, his MD at the University of Sheffield, a postdoctoral fellowship at Harvard Medical School and an MPhil in epidemiology from the University of Cambridge.

Professor Ray’s research interests focus on preventing the global consequences of atherosclerosis through large-scale population studies evaluating the burden of disease and improving risk prediction and through the study of novel therapies in the setting of multi-centre international clinical trials to offer solutions to help prevent death and disability from cardiovascular disease. As such, he is the global PI of several ongoing Cardiovascular trials and registries.

His publications are included in the NEJM, Lancet, JAMA, Circulation, JACC and EHJ amongst others and have received over 54,000 citations (2019 H index of 68, i10 of 159) and in 2018 he was listed by Clarivate Analytics as among the top 1% of authors cited globally in clinical medicine.

The impact of his novel research findings has contributed to current US and European guidelines amongst others.

An active member of the EAS, Professor Ray has contributed to more than 6 EAS Consensus Panel statements, been an invited speaker at the EAS annual congress for several years, was an EAS program committee member for 2015 (Glasgow) and 2017 (Prague) as well as his ongoing contributions to masterclasses and other EAS educational activities. Since 2017 he has served on the EAS Executive committee.

In 2014 he independently initiated and obtained funding for the EAS FH studies collaboration, the first global registry of its kind, now encompassing over 68 countries and approximately 60,000 cases, for which he is the lead.

Prof Ray has worked extensively to extend the EAS mission across Europe, the Asia Pacific, Gulf region and Latin America through education and collaborations.

Professor Stephen Nicholls
MBBS, Ph.D., FRACP, FACC, FESC, FAHA, FCSANZ, FAHMS
Director of MonashHeart, Monash Health
Director of Victorian Heart Institute, Monash University
Professor of Cardiology, Monash University

Professor Steve Nicholls is the Director of MonashHeart, Director of Victorian Heart Institute and Professor of Cardiology at Monash University. He will be the Director of the Victorian Heart Hospital.
He completed his cardiology training at John Hunter Hospital and PhD at the University of Adelaide, prior to holding a postdoctoral fellowship and faculty appointment at the Cleveland Clinic and the South Australian Health and Medical Research Institute.
His research interests focus on the role of metabolic risk factors and imaging in atherosclerosis, with work spanning from early discovery to leadership of large clinical trials.
He is Chair of the Australian Atherosclerosis Society Clinical Council, Australia and New Zealand Alliance for Cardiovascular Trials, Asia Pacific Cardiometabolic Consortium, President Elect of the Cardiac Society of Australia and New Zealand and a Fellow of the Australian Academy of Health and Medical Sciences.